West Pharmaceutical Companies, Inc. (NYSE:WST) introduced a quarterly dividend on Wednesday, January fifth, Zacks experiences. Shareholders of document on Wednesday, January nineteenth shall be given a dividend of 0.18 per share by the medical devices provider on Wednesday, February 2nd. This represents a $0.72 dividend on an annualized foundation and a yield of 0.18%. The ex-dividend date of this dividend is Tuesday, January 18th.
West Pharmaceutical Companies has elevated its dividend by 22.6% over the past three years and has elevated its dividend yearly for the final 28 years. West Pharmaceutical Companies has a dividend payout ratio of 8.0% that means its dividend is sufficiently lined by earnings. Analysts count on West Pharmaceutical Companies to earn $9.01 per share subsequent 12 months, which implies the corporate ought to proceed to have the ability to cowl its $0.72 annual dividend with an anticipated future payout ratio of 8.0%.
NYSE:WST opened at $407.74 on Friday. West Pharmaceutical Companies has a 1 12 months low of $253.85 and a 1 12 months excessive of $475.35. The enterprise has a fifty day easy shifting common of $437.23 and a two-hundred day easy shifting common of $422.34. The corporate has a debt-to-equity ratio of 0.10, a present ratio of two.86 and a fast ratio of two.23. The corporate has a market capitalization of $30.21 billion, a P/E ratio of fifty.59, a P/E/G ratio of two.00 and a beta of 0.97.
West Pharmaceutical Companies (NYSE:WST) final posted its quarterly earnings outcomes on Thursday, October twenty eighth. The medical devices provider reported $2.06 EPS for the quarter, topping the Zacks’ consensus estimate of $1.80 by $0.26. West Pharmaceutical Companies had a return on fairness of 30.35% and a internet margin of twenty-two.85%. The agency had income of $706.50 million through the quarter, in comparison with analyst estimates of $687.09 million. Throughout the identical interval final 12 months, the corporate earned $1.15 earnings per share. The enterprise’s income for the quarter was up 28.9% on a year-over-year foundation. As a bunch, analysts anticipate that West Pharmaceutical Companies will submit 8.49 earnings per share for the present 12 months.
Individually, Zacks Investment Research lowered West Pharmaceutical Companies from a “purchase” ranking to a “maintain” ranking and set a $438.00 worth goal for the corporate. in a report on Friday, November twelfth.
About West Pharmaceutical Companies
West Pharmaceutical Companies, Inc manufactures and markets prescribed drugs, biologics, vaccines and shopper healthcare merchandise. It operates by the next enterprise segments: Proprietary Merchandise and Contract-Manufactured Merchandise. The Proprietary Merchandise section presents proprietary packaging, containment and drug supply merchandise, together with analytical lab providers, to biologic, generic and pharmaceutical drug prospects.
Learn Extra: What is an Initial Coin Offering (ICO)?
This instantaneous information alert was generated by narrative science know-how and monetary information from MarketBeat to be able to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial crew previous to publication. Please ship any questions or feedback about this story to [email protected]
Earlier than you contemplate West Pharmaceutical Companies, you will need to hear this.
MarketBeat retains observe of Wall Avenue’s top-rated and finest performing analysis analysts and the shares they suggest to their shoppers each day. MarketBeat has recognized the 5 shares that high analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and West Pharmaceutical Companies wasn’t on the listing.
Whereas West Pharmaceutical Companies at present has a “Purchase” ranking amongst analysts, top-rated analysts consider these 5 shares are higher buys.